Effectiveness of meditative movement on COPD: a systematic review and meta-analysis.
Author: Wu LL1, Lin ZK2, Weng HD3, Qi QF1, Lu J4, Liu KX5
Affiliation:
1Department of Respiratory Medicine, Fuzhou Pulmonary Hospital, Fuzhou, People's Republic of China.
2Department of Rehabilitation, No. 175 Hospital of PLA, Zhangzhou, Fujian, People's Republic of China.
3Postgraduate Institute of Fujian Medical University, Fuzhou, People's Republic of China.
4Department of Medical Oncology, Fuzhou Pulmonary Hospital, Fuzhou, People's Republic of China.
5Department of Respiratory Medicine, The First Affiliated Hospital, Fujian Medical University, Fuzhou, People's Republic of China.
Conference/Journal: Int J Chron Obstruct Pulmon Dis.
Date published: 2018 Apr 17
Other:
Volume ID: 13 , Pages: 1239-1250 , Special Notes: doi: 10.2147/COPD.S159042. eCollection 2018. , Word Count: 243
Background: The effectiveness of meditative movement (tai chi, yoga, and qigong) on COPD remained unclear. We undertook a systematic review and meta-analysis to determine the effectiveness of meditative movement on COPD patients.
Methods: We searched PubMed, Web of Science, EMBASE, and the Cochrane Center Register of Controlled Trials for relevant studies. The methods of standard meta-analysis were utilized for identifying relevant researches (until August 2017), quality appraisal, and synthesis. The primary outcomes were the 6-minute walking distance (6MWD), lung function, and dyspnea levels.
Results: Sixteen studies involving 1,176 COPD patients were included. When comparing with the control group, the 6MWD was significantly enhanced in the treatment group (3 months: mean difference [MD]=25.40 m, 95% CI: 16.25 to 34.54; 6 months: MD=35.75 m, 95% CI: 22.23 to 49.27), as well as functions on forced expiratory volume in 1 s (FEV1) (3 months: MD=0.1L, 95% CI: 0.02 to 0.18; 6 months: MD=0.18L, 95% CI: 0.1 to 0.26), and FEV1 % predicted (3 months: 4L, 95% CI: 2.7 to 5.31; 6 months: MD=4.8L, 95% CI: 2.56 to 7.07). Quality of life for the group doing meditative movement was better than the control group based on the Chronic Respiratory Disease Questionnaire dyspnea score (MD=0.9 units, 95% CI: 0.51 to 1.29) and fatigue score (MD=0.75 units, 95% CI: 0.42 to 1.09) and the total score (MD=1.92 units, 95% CI: 0.54 to 3.31).
Conclusion: Meditative movement may have the potential to enhance lung function and physical activity in COPD patients. More large-scale, well-designed, multicenter, randomized controlled trials should be launched to evaluate the long-range effects of meditative movement.
KEYWORDS: COPD; meditative movement; meta-analysis; qigong; tai chi; yoga
PMID: 29713157 PMCID: PMC5909800 DOI: 10.2147/COPD.S159042
BACK
